Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Case reports
Print version ISSN 2462-8522
Abstract
CHACON-ACEVEDO, Kelly Rocío et al. TOXICODERMIA AS AN ADVERSE EVENT IN A COVID-19 PATIENT: CASE REPORT. Case reports [online]. 2021, vol.7, n.1, pp.74-80. Epub June 04, 2021. ISSN 2462-8522. https://doi.org/10.15446/cr.v7n1.88223.
Introduction:
SARS-COV2 infection, which was initially associated with respiratory manifestations only, can also cause gastrointestinal, kidney, neurological and cardiovascular symptoms according to some reports.
Case presentation:
A 36-year-old female patient attended the emergency department due to dyspnea, asthenia, adynamia, mild odynophagia. and headache. The patient's medical history included obesity, smoking, and working as a health care worker. Considering the symptoms, antimalarial and antiretroviral treatment was indicated to treat COVID-19, a diagnosis that was confirmed three days after admission. However, on the fourth day of treatment, the patient presented with polydipsia and macular, pruritic, and generalized rash. Due to suspicion of toxicoderma, the treatment was suspended, and the skin condition improved. After 8 days of hospitalization, the patient was discharged with biosecurity recommendations and mandatory isolation for 28 days.
Conclusion:
The described case is a report of toxicoderma in a patient with COVID-19 under treatment with antiretroviral and antimalarial drugs. Based on the findings, a thorough examination of skin and mucosa of patients with suspected or confirmed COVID-19 will undoubtedly contribute to the correct characterization of this new disease.
Keywords : COVID-19; Coronavirus Infections; Drug-Related Side Effects and Adverse Reactions; Medication Therapy; Lopinavir.